Author: Ershad Moradi

Annual Product Review

Annual Product Review (APR) in Pharma: The Ultimate FDA vs EU PQR Checklist

The Annual Product Review (APR) is a vital component in pharmaceutical quality systems, reviewing yearly product data to ensure compliance and identify improvement opportunities. It reinforces audit readiness by providing transparent, trend-based insights that drive continuous quality assurance and risk mitigation, ultimately safeguarding patient safety and regulatory compliance.

Read More »

Release for Distribution in Pharma Manufacturing: a 2026 Guide on GMP Controls, Roles, and Required Documents

Release for Distribution requires Quality Unit authorization confirming all specifications met per WHO GDP Chapter 8, alongside logistics verification of temperature control, documentation, and shipping readiness before patient delivery. This dual authorization ensures regulatory compliance and product integrity throughout the supply chain. Understanding these processes prevents delays and protects patient safety by maintaining GMP standards and traceability requirements.

Read More »
Sampling Plan

Sampling Plan in Pharma: GMP, FDA/EMA Expectations, and QC Workflow

A pharmaceutical sampling plan ensures that tested samples truly represent the entire batch. Because results determine product release, regulators require representative collection, justified sample size, controlled handling, and full documentation. Strong sampling practices reduce risk, support compliance, and protect patient safety.

Read More »